课题基金 / 基金详情

Role of MiT Transcription Factors in Host Defense Against Bacterial Infection

Role of MiT Transcription Factors in Host Defense Against Bacterial Infection
MiT 转录因子在宿主防御细菌感染中的作用
批准号:
8273315
负责人:
Javier Elbio Irazoqui
金额:
$33.09万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-04-01 至 2017-01-31

项目摘要

项目成果

Javier Elbio Irazoqui的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):肠上皮的一个关键功能是区分共生微生物和致病微生物,从而避免传染病和慢性炎症;然而,对于肠上皮细胞(IECs)如何在顶端表面感知细菌并转导信号以驱动适当的转录反应,人们知之甚少。本研究的长期目标是阐明IEC和微生物调控网络之间的关系,这些调控网络决定了体内宿主-微生物相互作用的结果。本提案的总体目标是阐明由MITF-TFE (MiT)家族转录因子(tf)介导的决定宿主对感染的IEC反应的途径。因为MiT家族tf是高度保守的,我们选择使用秀丽隐杆线虫,一种遗传上可处理的模式生物,作为解决这些问题的工具。秀丽隐杆线虫表现出独立于TLR、NLR和NF-kB的病原体特异性反应,因此代表了一种有用的工具,可以在体内以无偏倚的方式研究进化保守的新型宿主防御途径。该建议的中心假设是,在致病性感染期间激活的未知信号通路控制了秀丽隐杆线虫和人类iec中mit介导的宿主防御。这项拟议研究的基本原理是,一旦了解了MiT tf在宿主反应中的功能以及它们在体内是如何被调节的,它们的活性就可能被药理学操纵,从而为预防和治疗各种感染性或炎症性疾病提供新的创新方法。为了验证中心假设,提出了三个具体目标:1)利用镶嵌遗传分析、翻译后修饰的生化表征和候选上游途径的遗传分析来阐明HLH-30/MiT的上游调控因子;2)利用全局基因表达谱和染色质免疫沉淀方法阐明HLH-30/MiT的下游靶标途径;3)利用生物化学、分子和细胞生物学方法结合高通量基因表达谱,阐明MiT tf在人类IEC宿主防御中的作用。这项研究的贡献是阐明新的、非tlr /NLR/NF-¿B、HLH-30/ mit介导的调节秀丽隐杆线虫和人类IECs中宿主对细菌反应的途径。这些贡献是重要的,因为它们是连续研究的第一步,最终将允许通过MiT信号对宿主防御进行药理学操作,无论是积极的还是消极的,以治疗感染或炎症性疾病。这项拟议的研究在概念上具有创新性,因为它首次表明,在微生物刺激和肠道炎症期间,MiT tf在人类iec中存在差异表达。此外,拟议的研究具有创新性,因为它代表了与更直接的体外方法的背离,并利用了秀丽隐杆线虫的可跟踪性,因此是一种公正和有效的体内方法。
英文摘要
DESCRIPTION (provided by applicant): A key function of the intestinal epithelium is to discriminate commensal from pathogenic microbes and thus avoid infectious disease and chronic inflammation; however, little is known about how intestinal epithelial cells (IECs) sense bacteria at the apical surface and transduce the signals to drive appropriate transcriptional responses. The long-term goal of this research is to elucidate relationships between IEC and microbe regulatory networks that determine the outcome of host-microbe interactions in vivo. The overall objective of this proposal is to elucidate pathways mediated by MITF-TFE (MiT) family transcription factors (TFs) that determine the host IEC response to infection. Because MiT family TFs are highly conserved, we chose to use Caenorhabditis elegans, a genetically tractable model organism, as a tool to address these questions. C. elegans exhibits pathogen-specific responses that are independent of TLR, NLR, and NF-kB, and thus represents a useful tool to study novel host defense pathways that are evolutionarily conserved, in an unbiased manner in vivo. The central hypothesis of this proposal is that unknown signaling pathways activated during pathogenic infection control MiT-mediated host defense in C. elegans and human IECs. The rationale for the proposed research is that, once it is understood how MiT TFs function in the host response and how they are regulated in vivo, their activity could likely be manipulated pharmacologically, resulting in new and innovative approaches for the prevention and treatment of a variety of infectious or inflammatory diseases. To test the central hypothesis, three specific aims are proposed: 1) Elucidate upstream regulators of HLH-30/MiT, using mosaic genetic analysis, biochemical characterization of post-translational modifications, and genetic analysis of candidate upstream pathways; 2) Elucidate downstream target pathways of HLH-30/MiT, using global gene expression profiling and chromatin immunoprecipitation approaches, and 3) Elucidate the role of MiT TFs in human IEC host defense, using human IEC lines in biochemical, molecular, and cell biological approaches cou- pled with high-throughput gene expression profiling. The contribution of the proposed research is expected to be the elucidation of novel, non-TLR/NLR/NF-¿B, HLH-30/MiT-mediated pathways regulating the host response to bacteria in C. elegans and human IECs. These contributions are significant because they are the first step in a continuum of research that will eventually allow pharmacologic manipulation of host defense via MiT signaling, either positively or negatively, to treat infection or inflammatory disease. The proposed research is conceptually innovative because it shows for the first time that MiT TFs are differentially expressed in human IECs during microbial stimulation and intestinal inflammation.Furthermore, the proposed research is innovative because it represents a departure from more directed in vitro approaches and takes advantage of the tractability of C. elegans, and thus is an unbiased and efficient in vivo approach. PUBLIC HEALTH RELEVANCE: The proposed research is relevant to public health because the signaling components identified upon successful completion of these studies are likely to provide new targets for prevention and treatment of intestinal infectious or inflammatory disease and significantly advance the field of host-microbe interactions. The research proposed here is expected to enable further exploration of the role of MITF/TFE (MiT) transcription factors, in the context of other signaling pathways in vertebrate genetic models of intestinal infection and inflammatory disease. The project is relevant to the mission of the NIH because the knowledge acquired with the proposed studies will increase the repertoire of pathways that control host defense and MRSA pathogenesis, leading to greater understanding of disease, enabling research to identify new targets for treatment, and having the po- tential to accelerate the development of new therapies, reducing the burden of a variety of infections and in- flammatory diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FLAVIN-CONTAINING MONO-OXYGENASES AS NOVEL INNATE IMMUNITY EFFECTORS
Mechanisms of the gut-brain axis that regulate innate immunity
Role of MiT Transcription Factors in Host Defense Against Bacterial Infection
  • 批准号:
    8610327
  • 项目类别:
  • 资助金额:
    $38.92万
  • 财政年份:
    2012
  • 负责人:
    Javier Elbio Irazoqui
  • 依托单位:
Role of MiT Transcription Factors in Host Defense Against Bacterial Infection
海外基金